United States · FDA National Drug Code directory
OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-249_44b62ded-18e8-b2e8-e063-6294a90ac180
- Product NDC
- 42571-249
- Form
- TABLET, FILM COATED
- Composition / generic term
- Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260301
- Source listing expiry
- 20261231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 40 mg/1
- AMLODIPINE BESYLATE — 10 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (42571-249-05) · 42571-249-05
- 1000 TABLET, FILM COATED in 1 BOTTLE (42571-249-10) · 42571-249-10
- 30 TABLET, FILM COATED in 1 BOTTLE (42571-249-30) · 42571-249-30
- 90 TABLET, FILM COATED in 1 BOTTLE (42571-249-90) · 42571-249-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →